enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Adenosine deaminase 2 deficiency - Wikipedia

    en.wikipedia.org/wiki/Adenosine_deaminase_2...

    Adenosine deaminase 2 deficiency. Deficiency of Adenosine deaminase 2 ( DADA2) is a monogenic disease associated with systemic inflammation and vasculopathy that affects a wide variety of organs in different patients. As a result, it is hard to characterize a patient with this disorder. Manifestations of the disease include but are not limited ...

  3. Adenosine deaminase deficiency - Wikipedia

    en.wikipedia.org/wiki/Adenosine_deaminase_deficiency

    Adenosine deaminase deficiency ( ADA deficiency) is a metabolic disorder that causes immunodeficiency. It is caused by mutations in the ADA gene. It accounts for about 10–20% of all cases of autosomal recessive forms of severe combined immunodeficiency (SCID) after excluding disorders related to inbreeding. [ 1][ 2] ADA deficiency can present ...

  4. Haemophilia - Wikipedia

    en.wikipedia.org/wiki/Haemophilia

    Haemophilia. Haemophilia ( British English ), or hemophilia ( American English) [ 6] (from Ancient Greek αἷμα (haîma) 'blood' and φιλία (philía) 'love of'), [ 7] is a mostly inherited genetic disorder that impairs the body's ability to make blood clots, a process needed to stop bleeding. [ 2][ 3] This results in people bleeding for ...

  5. Leading a healthier lifestyle can help offset genetic heart ...

    www.aol.com/leading-healthier-lifestyle-help...

    The researchers found that the high genetic risk group had a 14.7-fold risk reduction in incidences of early-onset coronary artery disease, a 2.5-fold risk reduction in early-onset ischemic stroke ...

  6. Alzheimer's drug from Eisai and Biogen rejected in Europe - AOL

    www.aol.com/news/eu-medicines-regulator-rejects...

    By Manas Mishra and Puyaan Singh. (Reuters) -The European Union's drugs regulator has rejected Eisai and Biogen's Leqembi treatment for early Alzheimer's disease, saying the risk of serious brain ...

  7. Ascendis Pharma's hormone disorder therapy gets US approval - AOL

    www.aol.com/fda-approves-ascendis-pharmas...

    August 12, 2024 at 7:22 AM. (Reuters) -Ascendis Pharma's said on Monday the U.S. Food & Drug Administration had approved its therapy to treat adult patients with a hormone disorder. Ascendis ...

  8. XX male syndrome - Wikipedia

    en.wikipedia.org/wiki/XX_male_syndrome

    De la Chapelle syndrome [ 1] Human karyotype 46 XX. Specialty. Medical genetics. XX male syndrome, also known as de la Chapelle syndrome, is a rare condition in which an individual with a 46,XX karyotype develops a male phenotype. [ 2] Synonyms for XX male syndrome include 46,XX testicular difference of sex development (or 46,XX DSD) [ 3][ 4 ...

  9. Homeobox protein Nkx-2.5 - Wikipedia

    en.wikipedia.org/wiki/Homeobox_protein_Nkx-2.5

    The NKX2-5 transcription factor may help myocytes endure cytotoxic stress, however further exploration in this field is required. [8] NK-2 homeobox genes are a family of genes that encode for numerous transcription factors that go on to aid in the development of many structures including the thyroid, colon, and heart.